Dr. Reddy's Laboratories Limited (DRREDDY) — Board Meeting | 23 July 2026(3 announcements)

At the 42nd Annual General Meeting on July 23, 2026, Dr. Reddy's Laboratories approved the re-appointment of Dr. K P Krishnan as Independent Director for a second term from January 7, 2027 to January 6, 2032, the appointment of Srikanth Velamakanni as Independent Director for a five-year term from July 1, 2026 to June 30, 2031, and the appointment of Deloitte Haskins & Sells LLP as Statutory Auditors for five years until the 47th AGM. ₹X crores in audit fees were disclosed in Annexures, though the exact amount was not specified in the filing.

At the 42nd Annual General Meeting held on July 23, 2026, shareholders approved the re-appointment of Dr. K P Krishnan as an Independent Director for a second term from January 7, 2027 to January 6, 2032, and the appointment of Srikanth Velamakanni as an Independent Director for a five-year term from July 1, 2026 to June 30, 2031. Additionally, Deloitte Haskins & Sells LLP was reappointed as the statutory auditor for a five-year term ending at the 47th AGM. These governance updates strengthen board expertise and audit oversight without altering financial performance or capital structure.

Dr. Reddy's Laboratories held its 42nd Annual General Meeting on July 23, 2026 via video conferencing, with 86 shareholders representing 22.26 crore shares in attendance. All agenda items, including adoption of FY2025-26 financial statements, declaration of an Rs. 8 final dividend per share, re-appointment of directors, auditor appointment, and remuneration ratification, were passed with requisite majorities. Voting was conducted through remote e-voting and on-site electronic voting, with results confirmed by the Scrutinizer's report.